Advances in technology have led computed tomography (CT) to become one of the main diagnostic tools utilized today in modern healthcare, as it provides a safe and low risk anatomical visualization of the human body. However, these advances have also introduced new challenges related to the administration of contrast, which is a fundamental component of many CT imaging exams, particularly in cardiac CT.
This Expert Forum aims to help a wider audience of radiology professionals understand how to use iodine contrast safely, by using a weight-based contrast strategy, which allows technologists and radiologists to image safely while obtaining optimal results. In addition, we will discuss the value of including saline in your protocols, which can result in contrast savings, but also provides the ability to optimize the contrast injection process to improve image quality and patient safety.
Following the presentation questions from the audience were addressed in a moderated Q&A session.
CME Effective Date: November 1, 2018
CME Expiration Date: October 31, 2020
CE Effective Date: January 28, 2019
CE Expiration Date: January 31, 2020
Format: Self Instructional - Audio Visual with Slides
One (1) AMA/PRA Category 1 CME Credit™
One (1) ARRT Category A CE Credit.
One (1) AHRA CRA Credit
Estimated Completion Time: 1 hour
This program is supported through an unrestricted educational grant from Bracco Diagnostics Inc.
This program is intended for: Radiologists, Other MD's, Radiologic Technologists, Radiology Administrators and related Imaging Professionals.
There is no cost to participate in this program.
Upon completion of this CME activity the healthcare provider should be able to:
No special educational preparation is required for this CME/CE Activity!
Dominik Fleischmann, MD
Professor of Radiology
My clinical and research interests include imaging technology in general – notably the use of CT and MR along with techniques and applications for optimizing non-invasive cardiovascular imaging, image-based diagnosis, and treatment planning for cardiovascular disease.
I prefer a bedside-to-bench approach when developing visualization tools for vascular imaging; aimed at solving imaging problems with the tremendous advances in imaging technology and new treatment options that have evolved in the last few decades.
Lior Molvin, MBA, RT CT
I began my career at the Stanford University Medical Center in 2006. I have extensive experience with both hospital and outpatient diagnostic equipment and procedures as well as in-depth knowledge of Stanford CT protocols, policies, and procedures. I wear many hats at Stanford and my current roles include:
• Clinical technologist on the CT protocol and educational development team
• Manage outpatient, inpatient, and nuclear medicine diagnostic CT protocols
• Key contributor to the training mechanisms at Stanford Hospital and Clinics
• Key player in the implementation of Dosewatch, radiation dose management system
• Educational project coordinator focused on technologist education and development
• CT research and development
I have experience with dual energy CT applications and post processing. In depth experience with the integration of iterative reconstruction systems as a dose reduction strategy in CT.
IAME requires everyone who is in a position to control the content of a CE/CME activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CE/CME activity certified by IAME.
Dominik Fleischmann, MD, has nothing to disclose.
Lior Molvin, MBA, RT CT, has nothing to disclose.
No individual at IAME who had control over the content of this program has relationships with Philips Healthcare or any other commercial supporter.
The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Institute for Advanced Medical Education (IAME) designates this enduring material for a maximum of 1 AMA/PRA Category 1 CME Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for One (1) ARRT Category A CE Credit.
This course meets all CRA renewal credit criteria and has been approved for one (1) continuing education credit in the following CRA domains: Asset Resource Management (AM) and Operations Management (OM).
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.
To receive CME credits for participating in this CME activity you must successfully complete the online post examination with a passing score of 70% or higher.
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.
Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.